Harvey Capital Management’s CRISPR Therapeutics CRSP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-2,500	Closed	-$304K	–	80
2021 Q1	$304K	Hold	2,500	–	–	0.11%	73
2020 Q4	$382K	Buy	+2,500	New	+$382K	0.16%	62